PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-21

Date Title Company
21-Feb-2024 DC Healthcare Announces Expansion with New Branches in Johor Bahru and Ipoh DC Healthcare
21-Feb-2024 Biotricity Strengthens its Foundation for Growth, Achieves Lower Cost of Sales, Expanding Margins of 73% and Increased Device Sales, for Third Quarter of Fiscal Year 2024 AccessWire
21-Feb-2024 Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy Mainz BioMed N.V.
21-Feb-2024 Ensysce Biosciences Announces Successful Meeting with FDA for PF614-MPAR, a Next Generation Opioid with Overdose Protection AccessWire
21-Feb-2024 AllStar Health Brands Inc. Acquires Major Interest in Italian Football Club Sanremo; Expands Sports Operations to North America AccessWire
21-Feb-2024 Tenon Medical, Inc. Raises Approximately $2.6 Million in Series A Preferred Stock AccessWire
21-Feb-2024 Renalogic Experiences Record Growth in 2023 AccessWire
21-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
21-Feb-2024 Cresset® Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology Cresset
21-Feb-2024 Cambridge Cognition and ActiGraph Announce Partnership to Accelerate Adoption of Digital Measurements for Central Nervous System Trials Cambridge Cognition Holdings plc
21-Feb-2024 Cambridge Cognition and ActiGraph Announce Partnership to Accelerate Adoption of Digital Measurements for Central Nervous System Trials Cambridge Cognition Holdings plc
21-Feb-2024 KL KREMS RECEIVES ACCREDITATION FOR PHD PROGRAMME "MENTAL HEALTH AND NEUROSCIENCE" Karl Landsteiner University of Health Sciences
21-Feb-2024 Rejuvenate Biomed’s clinical trial demonstrates the therapeutic potential of RJx-01 in sarcopenia Rejuvenate Biomed NV
21-Feb-2024 LATITUDE phase III interim trial data indicates ViiV Healthcare’s long-acting injectable HIV treatment Cabenuva (cabotegravir + rilpivirine) has superior efficacy compared to daily therapy in individuals living with HIV who have adherence challenges GSK 
21-Feb-2024 INMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Businesswire
21-Feb-2024 Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD Evaxion Biotech A/S
21-Feb-2024 Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its Lead Oncology Program Mestag Therapeutics
21-Feb-2024 Conference call on the results for the 1st quarter 2023/24 (ending 31 December 2023) on 22 February 2024 Douglas GmbH
21-Feb-2024 Bioz and Gamry Instruments Partner to Provide Customers With Product Validation Knowledge AccessWire
21-Feb-2024 Innate Pharma Announces Its Participation to Upcoming Investor Conference Businesswire